Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
10/29/2009 | WO2009131179A1 Yeast mutant and substance production process using the same |
10/29/2009 | WO2009131166A1 Wnt signaling inhibitor comprising insulin-like growth factor-binding protein |
10/29/2009 | WO2009131040A1 Genetically modified coryneform bacteria capable of producing isopropanol |
10/29/2009 | WO2009130797A1 Probe set for determining abo blood type |
10/29/2009 | WO2009130697A1 Polynucleotides and polypeptides encoded thereby and use thereof in increasing binding affinity of dna binding proteins |
10/29/2009 | WO2009130616A2 Improved tlr3 agonist compositions |
10/29/2009 | WO2009130612A2 Prion epitopes and methods of use thereof |
10/29/2009 | WO2009130598A1 Genetically modified eukaryotic cells |
10/29/2009 | WO2009130520A1 Method for the annotation of natural product gene-clusters and for the generation of novel biologically active chemical entities from dna sequences in silico |
10/29/2009 | WO2009130479A2 Virus |
10/29/2009 | WO2009130296A2 Anti-alk1 antibodies and uses thereof |
10/29/2009 | WO2009130247A1 Hybrid h1 promoter for shrna expression |
10/29/2009 | WO2009130208A1 Liver-specific nucleic acid regulatory elements and methods and use thereof |
10/29/2009 | WO2009130031A1 Artificial protein scaffolds |
10/29/2009 | WO2009129797A2 Stable lysis buffer mixture for extracting nucleic acids |
10/29/2009 | WO2009129743A1 Gif1 promoter and uses thereof |
10/29/2009 | WO2009129616A1 Genetically modified human umbilical cord perivascular cells for prophylaxis against or treatment of biological or chemical agents |
10/29/2009 | WO2009129583A1 Recombinant cells and methods for hydroxylating fatty acids |
10/29/2009 | WO2009129582A1 Polypeptides and methods for producing triacylglycerols comprising modified fatty acids |
10/29/2009 | WO2009111658A3 Compositions and methods for inhibiting expression of eg5 and vegf genes |
10/29/2009 | WO2009111375A3 Treatment, diagnostic, and method for discovering antagonist using sparc specific mirnas |
10/29/2009 | WO2009106596A3 Plants with increased yield |
10/29/2009 | WO2009105786A3 Treatment for oral disease |
10/29/2009 | WO2009101400A3 Methods |
10/29/2009 | WO2009100159A3 Methods of diagnosing and treating parp-mediated diseases |
10/29/2009 | WO2009098450A3 Methods and compositions |
10/29/2009 | WO2009097418A3 Sr-bi as a predictor of elevated high density lipoprotein and cardiovascular disease |
10/29/2009 | WO2009096690A3 Improved promoter, and a production method for l-lysine using the same |
10/29/2009 | WO2009091228A3 Guanosine monophosphate kinase variant having reduced gmp conversion activity |
10/29/2009 | WO2009074970A3 Means for delivery of nucleic acids active for gene silencing using synthetic polymers |
10/29/2009 | WO2009073399A3 Engineering enzymatically susceptible proteins |
10/29/2009 | WO2009071920A3 Methods for identifying epigenetically silenced genes and novel tumour suppressor genes |
10/29/2009 | WO2009071082A9 Rna antagonist compounds for the modulation of pik3ca expression |
10/29/2009 | WO2009065022A3 Low density lipoprotein receptor-mediated sirna delivery |
10/29/2009 | WO2009046426A3 Compounds and methods for improving cellular uptake of oligomeric compounds |
10/29/2009 | WO2008101850A8 Method of producing methionine in corynebacteria by over-expressing enzymes of the pentose phosphate pathway |
10/29/2009 | WO2008099149A8 Method for incorporating proteins into lentivirus vectors |
10/29/2009 | US20090271896 Method for agrobacterium-mediated transformation of plants |
10/29/2009 | US20090271895 Plants having improved growth characteristics and method for making the same |
10/29/2009 | US20090271894 transgenic plant with mutant UPB1 (UPBEAT1) gene for increased cellulosic biomass per acre; fermentation to produce bioethanol; agronomics |
10/29/2009 | US20090271893 Nucleic Acid Sequences and Methods of Use for the Production of Plants with Modified Polyunsaturated Fatty Acids |
10/29/2009 | US20090271892 Lysophosphatidic acid acyltransferase genes and uses thereof |
10/29/2009 | US20090271891 Pathogen Inducible Plant Thehalose-6-Phophate Phophatase Gene Promoters and Regulatory Elements |
10/29/2009 | US20090271890 Method for obtaining a plant with a lasting resistance to a pathogen |
10/29/2009 | US20090271889 Production of polyhydroxybutyrate in switchgrass |
10/29/2009 | US20090271888 Chalcone synthase with modified active sites for improving plant defenses and pigment production |
10/29/2009 | US20090271887 Soybean variety a1007978 |
10/29/2009 | US20090271886 Soybean variety d5896414 |
10/29/2009 | US20090271885 Soybean variety d5142326 |
10/29/2009 | US20090271884 ES Cell-Derived Mice From Diploid Host Embryo Injection |
10/29/2009 | US20090271883 Abi1/hssh3bp1 conditional knockout mouse |
10/29/2009 | US20090271881 Meganuclease variants cleaving a dna target sequence from a rag gene and uses thereof |
10/29/2009 | US20090271879 Analogues of (-)-picropodophyllin, synthesis and uses thereof |
10/29/2009 | US20090271335 Totipotent, Nearly Totipotent or Pluripotent Mammalian Cells Homozygous or Hemizygous for One or More Histocompatibility Antigent Genes |
10/29/2009 | US20090270597 Fibronectin type III (Fn3) for use as diagnostic and treatment tools in gene therapy; identifying the amino acid sequence of a polypeptide molecule capable of binding to a specific binding partner (SBP) so as to form a polypeptide:SSP complex |
10/29/2009 | US20090270595 Il-1 related polypeptides |
10/29/2009 | US20090270592 Purified TNFR preparations |
10/29/2009 | US20090270591 Novel surface antigen |
10/29/2009 | US20090270506 Crystalline structure of oxidosqualene synthase |
10/29/2009 | US20090270489 Long-acting polypeptides and methods of producing same |
10/29/2009 | US20090270486 Human rnase iii and compositions and uses thereof |
10/29/2009 | US20090270485 Cell specific replication-competent viral vectors comprising a self processing peptide cleavage site |
10/29/2009 | US20090270484 WWOX Vectors and Uses in Treatment of Cancer |
10/29/2009 | US20090270483 polynucleotides and polypeptides which are under-expressed in cancer and dysplasia delivered therapeutically to reduce the abnormal characteristics of cancer and dysplastic cells |
10/29/2009 | US20090270482 Analysis of methylated nucleic acid |
10/29/2009 | US20090270481 MODIFIED siRNA MOLECULES AND USES THEREOF |
10/29/2009 | US20090270333 Methods of using motilin homologs |
10/29/2009 | US20090270331 Multi-domain amphipathic helical peptides and methods of their use |
10/29/2009 | US20090270327 Lepidopteran-Active Bacillus Thuringiensis Delta-Endotoxin Compositions and Methods of Use |
10/29/2009 | US20090270325 Growth factor |
10/29/2009 | US20090270324 Complement depletion using recombinant human c-3 derivatives |
10/29/2009 | US20090270316 Her-2 binding antagonists |
10/29/2009 | US20090270265 Molecular Characteristics of Non-Small Cell Lung Cancer |
10/29/2009 | US20090269852 Novel gene gms 01 |
10/29/2009 | US20090269851 Use of disk surface for electroporation of adherent cells |
10/29/2009 | US20090269850 containing a reduced amount of receptor-binding protein compared with the wild type; modified HVJ containing a reduced amount of HN protein |
10/29/2009 | US20090269844 Nucleic acids encoding a receptor for il-17 homologous polypeptides |
10/29/2009 | US20090269843 Hemopexin fusion proteins |
10/29/2009 | US20090269842 Transmembrane delivery peptide and bio-material comprising the same |
10/29/2009 | US20090269840 Kinase insert domain-containing receptor (KDR) specific immunoglobulin for monitoring tumor angiogenesis |
10/29/2009 | US20090269833 Using sterospecific carboxylesterase variant for bioremediation of pyrethroids; eliminating or reducing the concentration of a pyrethroid pesticide in a sample |
10/29/2009 | US20090269831 Modified cytosine deaminases |
10/29/2009 | US20090269829 Novel compositions with polymerase activity |
10/29/2009 | US20090269828 Acyltransferases for alteration of polyunsaturated fatty acids and oil content in oleaginous yeasts |
10/29/2009 | US20090269827 Thermophilic and thermoacidophilic metabolism genes and enzymes from alicyclobacillus acidocaldadarius and related organisms, methods |
10/29/2009 | US20090269820 Dna coding for polypeptide participating in biosynthesis of pladienolide |
10/29/2009 | US20090269811 Il-1 related polypeptides |
10/29/2009 | US20090269809 Thermostable ribonuclease h |
10/29/2009 | US20090269808 Virus coat protein variants with self-subtracting properties |
10/29/2009 | US20090269805 Novel Lipolytic Enzyme ELIP |
10/29/2009 | US20090269804 Methods for refolding proteins containing free cysteine residues |
10/29/2009 | US20090269802 Alpha 1,4-galactosyltransferase and dna encoding thereof |
10/29/2009 | US20090269801 Vector to Induce Expression of Recombinant Proteins under Anoxic or Microaerobic Conditions |
10/29/2009 | US20090269797 strains of zymomonas mobilis for fermentation of biomass |
10/29/2009 | US20090269795 Mutant alpha4betadelta GABAA receptor and methods of treating anxiety or irritability |
10/29/2009 | US20090269783 B7-H2 molecules, novel members of the B7 family and uses thereof |
10/29/2009 | US20090269781 Single-Molecule-Format Probe And Utilization Thereof |
10/29/2009 | US20090269762 for detecting the presence of the transgene/genomic insertion region; for transgenic glyphosate tolerance; genetic engineering |
10/29/2009 | US20090269755 Means and method for inducing exon-skipping |
10/29/2009 | US20090269752 Method for selecting nucleic acids that bond with high-affinity to a target |